9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
Eastern Cooperative Oncology Group
University of Southern California
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Washington University School of Medicine
Stony Brook University
Tempus AI
Cedars-Sinai Medical Center
Stanford University
Taproot Health
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
Celgene
InSightec
InSightec
OPKO Health, Inc.
InSightec
Peter MacCallum Cancer Centre, Australia
Novartis
Imunon
Peking University
InSightec
Stanford University
AstraZeneca
Bayer
Mannkind Corporation